Benitec Biopharma to present at Ladenburg Thalmann 2019 Healthcare Conference
Benitec Biopharma Inc. (BNTC)
US:NASDAQ Investor Relations:
benitec.com/for-investors/investor-faqs
Company Research
Source: PR Newswire
MELBOURNE, Australia, Sept. 19, 2019 /PRNewswire/ -- Benitec Biopharma Ltd (ASX: BLT, NASDAQ: BNTC), a gene therapy-focused biotechnology company developing novel genetic medicines derived from the proprietary DNA-directed RNA interference ("ddRNAi") platform, today announced that Jerel A. Banks, M.D. Ph.D., Executive Chairman and Chief Executive Officer of Benitec Biopharma will present at the Ladenburg Thalmann 2019 Healthcare Conference. Relevant details as follows: Date:Tuesday, September 24, 2019Event:Ladenburg Thalmann 2019 Healthcare ConferenceLocation:Sofitel, New York, NYTime:11:30 A.M. ESTA live webcast of the presentation will be streamed on the Investor Relations section of the Company's website, https://benitec.com/for-investors/events-and-presentations/, and a copy of the presentation will be released to the ASX, Nasdaq, and posted on the Company's website at the above URL prior to the event.About Benitec Biopharma LimitedBenitec Biopharma Limited (ASX: BLT; NASDAQ: BNT
Show less
Read more
Impact Snapshot
Event Time:
BNTC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTC alerts
High impacting Benitec Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
BNTC
News
- Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for OcAcquire Media Monitor
- Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development for OcGlobeNewswire
- Benitec Biopharma (BNTC) had its "buy" rating reaffirmed by TD Cowen.MarketBeat
- Benitec Biopharma (BNTC) had its "buy" rating reaffirmed by HC Wainwright. They now have a $32.00 price target on the stock.MarketBeat
- Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 Treatment at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference [Yahoo! Finance]Yahoo! Finance
BNTC
Earnings
- 2/12/26 - Miss
BNTC
Analyst Actions
- 3/9/26 - HC Wainwright
BNTC
Sec Filings
- 3/20/26 - Form 10-K/A
- 2/12/26 - Form 8-K
- 2/12/26 - Form 10-Q
- BNTC's page on the SEC website